申请人:Signum Biosciences, Inc.
公开号:US10314802B2
公开(公告)日:2019-06-11
Among other things, the present invention provides novel isoprenyl compounds capable of effectively modulating inflammatory responses and pharmaceutical, cosmetic, cosmeceutical and topical compositions comprising these isoprenyl compounds. Anti-inflammatory compounds of the present invention are useful in treating or preventing diseases or conditions associated with inflammation. Proinflammatory compounds of the present invention are useful in treating or preventing diseases or conditions associated with suppression of inflammatory responses. Thus, the present invention also provides methods useful in the treatment or prevention of diseases or conditions associated with inflammation as well as methods useful in the treatment or prevention of diseases or conditions associated with suppression of inflammatory responses.
除其他外,本发明提供了能够有效调节炎症反应的新型异戊烯基化合物,以及包含这些异戊烯基化合物的药物、化妆品、药妆和外用组合物。本发明的抗炎化合物可用于治疗或预防与炎症相关的疾病或病症。本发明的促炎化合物可用于治疗或预防与抑制炎症反应有关的疾病或病症。因此,本发明还提供了治疗或预防与炎症有关的疾病或病症的方法,以及治疗或预防与抑制炎症反应有关的疾病或病症的方法。